Roop Kalyan Lakkaraju
CIK 1396867 · View on SEC EDGAR ↗
Insider
First SEC filing: April 17, 2024 · Latest: April 17, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 50 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
50 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 4, 2021 | BHE | P | 100 | $25.95 | $2,595 | 76,400 Direct | +0.13% | Acquired | 186.0% (price as of 2026-08-21) |
| Aug. 3, 2021 | BHE | P | 1,800 | $26.37 | $47,466 | 76,300 Direct | +2.42% | Acquired | 181.4% (price as of 2026-08-21) |
| March 5, 2021 | BHE | P | 905 | $29.60 | $26,788 | 74,500 Direct | +1.23% | Acquired | 150.7% (price as of 2026-08-21) |
| March 2, 2021 | BHE | P | 1,680 | $29.64 | $49,795 | 73,595 Direct | +2.34% | Acquired | 150.4% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 24, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,078) | — | — | 1,078 | Disposed |
| Sept. 6, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,535) | — | — | 1,535 | Disposed |
| Sept. 5, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (5,480) | — | — | 5,480 | Acquired |
| April 24, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,077) | — | — | 1,077 | Disposed |
| March 3, 2025 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,891) | $256.45 | March 3, 2035 | 3,891 | Acquired |
| Sept. 6, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (6,143) | — | — | 6,143 | Acquired |
| April 24, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (4,311) | — | — | 4,311 | Acquired |
| Feb. 22, 2024 | BHE | Performance-Based Restricted Stock Units | Common Stock (25,321) | $0.00 | March 15, 2027 | 25,321 | Acquired |
| Feb. 20, 2024 | BHE | Performance-based Restricted Stock Units | Common Stock (19,516) | $0.00 | Dec. 31, 2023 | 19,516 | Disposed |
| Feb. 20, 2024 | BHE | Performance-based Restricted Stock Units | Common Stock (2,033) | $0.00 | Dec. 31, 2023 | 2,033 | Acquired |
| Feb. 23, 2023 | BHE | Performance-based Restricted Stock Units | Common Stock (27,653) | $0.00 | — | 27,653 | Acquired |
| Feb. 22, 2023 | BHE | Performance-based Restricted Stock Units | Common Stock (14,573) | $0.00 | — | 14,573 | Disposed |
| Feb. 22, 2023 | BHE | Performance-based Restricted Stock Units | Common Stock (5,831) | $0.00 | — | 5,831 | Acquired |
| Feb. 22, 2023 | BHE | Performance-based Restricted Stock Units | Common Stock (3,830) | $0.00 | — | 3,830 | Disposed |
| Feb. 22, 2023 | BHE | Performance-based Restricted Stock Units | Common Stock (13,983) | $0.00 | — | 13,983 | Disposed |
| Feb. 25, 2022 | BHE | Performance-based Restricted Stock Units | Common Stock (24,067) | $0.00 | — | 24,067 | Acquired |
| Feb. 19, 2021 | BHE | Performance-based Restricted Stock Units | Common Stock (17,483) | $0.00 | — | 17,483 | Acquired |
| Feb. 19, 2021 | BHE | Performance-based Restricted Stock Units | Common Stock (8,742) | $0.00 | — | 8,742 | Acquired |
| Feb. 20, 2020 | BHE | Performance-based Restricted Stock Units | Common Stock (17,813) | $0.00 | — | 17,813 | Acquired |
| Feb. 20, 2019 | BHE | Performance-based Restricted Stock Units | Common Stock (14,641) | $0.00 | — | 14,641 | Acquired |
| Feb. 20, 2018 | BHE | Performance-based Restricted Stock Units | Common stock (12,230) | $0.00 | — | 12,230 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $176,538 | — | — | — | — | — | $29,071 | $1,705,609 |
| 2023 | $520,035 | — | — | — | $261,890 | — | $46,571 | $2,178,496 |
| 2022 | $500,857 | — | — | — | $623,107 | — | $42,935 | $2,416,899 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.